There has been growing reports of the medical benefits of CBD oil (cannabidiol). Because of this, many patients have begun seeking out CBD varieties for treating conditions ranging from multiple sclerosis, severe epilepsy, certain cancers, pain and anxiety among others. CBD oil is derived from the whole plant extracts of the cannabis plant or industrial hemp. For years CBD has been overshadowed by tetrahydrocannabinol or THC, the most popular compound in certain strains of cannabis. This is because unlike THC, CBD doesn’t produce a psychoactive high. Nonetheless, CBD has been known to have anti-epileptic, anti-spasmodic, antipsychotic and anti-anxiety, properties. CBD has been reported to modulate chronic inflammatory issues using several mechanisms. These acute inflammatory issues range from joint pain to IBS (irritable bowel syndrome) and diabetic retinopathy.
The reduction of Inducible nitric oxide synthase and the reactive oxygen species by CBD, as well as the decline of lipid peroxidation, is proof of the important therapeutic action of CBD when it comes to the reduction of colonic inflammation via indirect reduction of oxidative damage. Additionally, the regulation of the interleukins IL-10 and IL-1B is a known disruption caused by irritable bowel syndrome (IBS). The restoration of the interleukins above to normal behavior by CBD, is another important therapeutic action CBD has on disruption of colonic inflammation.